PatenSee
PrivateLast Round
Seed
Feb 20, 2025
Total Funding Raised
$2.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PatenSee operates in Healthcare & Life Sciences and is based in Or Yehuda. Its latest recorded funding round was a Seed round in February 2025.
PatenSee is a medical devices company developing a non-contact monitoring system for the early detection of vascular access stenosis in hemodialysis patients using advanced, multi-modal imaging technologies and AI.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PatenSee Comparables
Compare PatenSee with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NephTech Pte Ltd | 87% | |
| Vexev | 84% | |
| Auvi Labs | 83% |
For institutional investors. Book with your work email.
PatenSee Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 20, 2025 | ||||
| Series A | Feb 24, 2022 | ||||
| Seed | May 18, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PatenSee Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| Biosciences Research and Commercialization Center at Western Michigan University | Seed |
| Israel Innovation Authority | Seed |
| Michigan Rise | Seed |
| Edge Medical Ventures | Seed |
| Spark Capital | Seed |
| MEDX Xelerator LP | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 455% MoM, from 199 to 1.1K.
- Jan 1, 2026
Paul Neeb, a seasoned early-stage CEO, will take over as CEO on January 1, 2026.
For institutional investors. Book with your work email.
PatenSee Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PatenSee's valuation, stock price, and market status.
Is PatenSee a public or private company?
PatenSee is a private company.
What is the current stock price of PatenSee?
PatenSee is a private company, so its shares have no public market price. Caplight tracks PatenSee's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PatenSee worth (valuation)?
Valuation information for PatenSee is not publicly available.
Can I buy PatenSee stock?
PatenSee shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PatenSee's last funding round?
PatenSee's most recent funding round was Seed on February 20, 2025.
Who are the main investors in PatenSee?
Key investors in PatenSee include Michigan Rise.
Will PatenSee IPO soon?
No public IPO plans have been announced for PatenSee.
How can I track PatenSee secondary market activity?
Caplight tracks bids, offers, and trades in PatenSee's shares on secondary markets.